Skip to main content
. 2020 Mar 17;9(3):742. doi: 10.3390/cells9030742

Figure 9.

Figure 9

Example of 3D bioprinted heart tissue patches used for drug screening. (A) Schematic representation of the extrusion-based 3D bioprinting system used to generate microfibrous alginate/gelatin methacrylate (GelMA) scaffolds encapsulating endothelial cells (ECs), that (B) in approximatively 2 weeks form a vascular bed through migration of cells to the peripheries of the microfibers. (C) Cardiomyocytes (CMs) are then seeded into the interstitial space of the endothelialized scaffold. The doxorubicin dose-concentration response is evaluated as (D) relative beating rate of CMs and (E) relative expression levels of von Willebrand factor (vWF) in ECs. Reprinted from Zhang et al. [116]. Copyright © 2020 Elsevier Ltd.